{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5f479e4b62ffcb0e230eadfe/5fd7399e399c7b6cd106082a?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"S1 #5 UK in Focus: Elimination is Possible","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/5f479e4b62ffcb0e230eadfe/1607950149849-f499405c35adca08d175600672cc3150.jpeg?height=200","description":"<p>In the first of our two ‘UK in Focus’&nbsp;episodes,&nbsp;our&nbsp;panel&nbsp;discusses the&nbsp;current status&nbsp;of&nbsp;hepatitis C elimination in the UK&nbsp;and share&nbsp;good practice initiatives that are making elimination possible.&nbsp;Our host, Dr Sarah Jarvis, is joined by&nbsp;Professor Graham Foster, Professor of Hepatology at Queen Mary University of London, Rachel Halford, CEO&nbsp;of&nbsp;the Hepatitis C Trust and Professor John Dillon, Professor of Hepatology and Gastroenterology at University of Dundee.&nbsp;</p><p><br></p><p><em>The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.</em></p><p>Job bag IHQ-HCV-2020-10-0073</p><p>Date of preparation: September 2022</p>","author_name":"World Hepatitis Alliance and Gilead Sciences Europe Limited"}